Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 1
1954 2
1960 1
1963 5
1964 2
1965 2
1966 1
1968 2
1970 3
1971 3
1975 1
1976 2
1978 4
1980 2
1981 3
1982 1
1983 2
1984 6
1985 12
1986 6
1987 4
1988 4
1989 3
1990 7
1991 4
1992 3
1993 2
1994 7
1995 4
1996 4
1997 5
1998 3
1999 3
2000 1
2001 5
2002 5
2003 7
2004 12
2005 11
2006 8
2007 19
2008 24
2009 18
2010 24
2011 29
2012 36
2013 45
2014 33
2015 26
2016 15
2017 17
2018 14
2019 16
2020 16
2021 19
2022 19
2023 16
2024 18

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

510 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group; ELATIVE Study Investigators' Group. Kowdley KV, et al. N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13. N Engl J Med. 2024. PMID: 37962077 Clinical Trial.
Diagnosis and Management of Primary Biliary Cholangitis.
Younossi ZM, Bernstein D, Shiffman ML, Kwo P, Kim WR, Kowdley KV, Jacobson IM. Younossi ZM, et al. Among authors: jacobson im. Am J Gastroenterol. 2019 Jan;114(1):48-63. doi: 10.1038/s41395-018-0390-3. Am J Gastroenterol. 2019. PMID: 30429590 Review.
Diagnosis and Management of Hepatitis Delta Virus Infection.
Pan C, Gish R, Jacobson IM, Hu KQ, Wedemeyer H, Martin P. Pan C, et al. Among authors: jacobson im. Dig Dis Sci. 2023 Aug;68(8):3237-3248. doi: 10.1007/s10620-023-07960-y. Epub 2023 Jun 20. Dig Dis Sci. 2023. PMID: 37338616 Free PMC article. Review.
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
Hirschfield GM, Bowlus CL, Mayo MJ, Kremer AE, Vierling JM, Kowdley KV, Levy C, Villamil A, Ladrón de Guevara Cetina AL, Janczewska E, Zigmond E, Jeong SH, Yilmaz Y, Kallis Y, Corpechot C, Buggisch P, Invernizzi P, Londoño Hurtado MC, Bergheanu S, Yang K, Choi YJ, Crittenden DB, McWherter CA; RESPONSE Study Group. Hirschfield GM, et al. N Engl J Med. 2024 Feb 29;390(9):783-794. doi: 10.1056/NEJMoa2312100. Epub 2024 Feb 21. N Engl J Med. 2024. PMID: 38381664 Clinical Trial.
Editorial: bodybuilders beware.
Feldman DM, Jacobson IM. Feldman DM, et al. Among authors: jacobson im. Aliment Pharmacol Ther. 2019 Jun;49(12):1530. doi: 10.1111/apt.15270. Aliment Pharmacol Ther. 2019. PMID: 31134650 No abstract available.
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Among authors: jacobson im. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b Study.
Abdelmalek MF, Sanyal AJ, Nakajima A, Neuschwander-Tetri BA, Goodman ZD, Lawitz EJ, Harrison SA, Jacobson IM, Imajo K, Gunn N, Halegoua-DeMarzio D, Akahane T, Boone B, Yamaguchi M, Chatterjee A, Tirucherai GS, Shevell DE, Du S, Charles ED, Loomba R. Abdelmalek MF, et al. Among authors: jacobson im. Clin Gastroenterol Hepatol. 2024 Jan;22(1):113-123.e9. doi: 10.1016/j.cgh.2023.04.012. Epub 2023 Apr 23. Clin Gastroenterol Hepatol. 2024. PMID: 37088458 Free article. Clinical Trial.
Viral hepatitis vaccines.
Jacobson IM, Dienstag JL. Jacobson IM, et al. Annu Rev Med. 1985;36:241-61. doi: 10.1146/annurev.me.36.020185.001325. Annu Rev Med. 1985. PMID: 3922284 Review.
Chronic Hepatitis B: Treat all Who Are Viremic?
Su F, Jacobson IM. Su F, et al. Among authors: jacobson im. Clin Liver Dis. 2023 Nov;27(4):791-808. doi: 10.1016/j.cld.2023.06.001. Epub 2023 Jul 27. Clin Liver Dis. 2023. PMID: 37778770 Review.
Telaprevir user's guide.
Liapakis A, Jacobson I. Liapakis A, et al. Among authors: jacobson i. Clin Liver Dis. 2011 Aug;15(3):555-71. doi: 10.1016/j.cld.2011.05.013. Clin Liver Dis. 2011. PMID: 21867936 Review.
510 results